Clinical Study

Stroke Prevention Trial Comparing Rivaroxaban To Aspirin At Preventing Another Stroke In Patients Who Recently Had A Stroke Of Undetermined Cause.

Posted Date: Feb 22, 2017

  • Investigator: Dawn Kleindorfer
  • Co-Investigator: Omar Lopez
  • Specialties: Neurosurgery, Stroke, Neurology
  • Type of Study: Drug

The purpose of this study is to compare two drugs in preventing blood clots, rivaroxaban and aspirin. The study drug rivaroxaban/Xarelto® has not yet been approved by the Federal Drug Administration (FDA) for secondary prevention of blood clots in th

Criteria:

We Are Asking You To Take Part In This Research Study Because You Are 18 Years Of Age Or Older And You Have Recently Had A Brain Attack (Also Called A Stroke) Due To A Lack Of Blood Flow To Part Of Your Brain That May Have Been Caused By A Blood Clot. In

Keywords:

Cerebrovascular Accident, Rivaroxaban, Stroke, Blood Clot, Aspirin

For More Information:

Alisha Hodge, Rn, Bsn
(513) 558-5149
alisha.hodge@uc.edu

  • Search Clinical Studies

  • Research in the News

    Ride Cincinnati Gives $200,000 in Grants for Breast Cancer Research

    Marlene Harris-Ride Cincinnati has continued its support of UC Cancer Institutescientists with the annual award of five grants to continue promising breastcancer research.